Cancer Stem Cell Marker Phenotypes are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer

Por Dosch, Joseph S., Ziemke, Elizabeth K., Shettigar, Amrith, Rehemtulla, Alnawaz, Sebolt-Leopold, Judith S.
Publicado no Cancer Res (2015)

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6

Por Ziemke, Elizabeth K., Dosch, Joseph S., Maust, Joel D., Shettigar, Amrith, Sen, Ananda, Welling, Theodore H., Hardiman, Karin M., Sebolt-Leopold, Judith S.
Publicado no Clin Cancer Res (2015)

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

Por Dosch, Joseph, Ziemke, Elizabeth, Wan, Shanshan, Luker, Kathryn, Welling, Theodore, Hardiman, Karin, Fearon, Eric, Thomas, Suneetha, Flynn, Matthew, Rios-Doria, Jonathan, Hollingsworth, Robert, Herbst, Ronald, Hurt, Elaine, Sebolt-Leopold, Judith
Publicado no Oncotarget (2017)

Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor

Por Ramkumar, Kavya, Samanta, Soma, Kyani, Anahita, Yang, Suhui, Tamura, Shuzo, Ziemke, Elizabeth, Stuckey, Jeanne A., Li, Si, Chinnaswamy, Krishnapriya, Otake, Hiroyuki, Debnath, Bikash, Yarovenko, Vladimir, Sebolt-Leopold, Judith S., Ljungman, Mats, Neamati, Nouri
Publicado no Nat Commun (2016)